142 related articles for article (PubMed ID: 33270865)
1. Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
Holsten T; Lubieniecki F; Spohn M; Mynarek M; Bison B; Löbel U; Rutkowski S; Schüller U
J Neuropathol Exp Neurol; 2021 Jan; 80(1):52-59. PubMed ID: 33270865
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report.
Furuta T; Moritsubo M; Muta H; Koga M; Komaki S; Nakamura H; Morioka M; Ohshima K; Sugita Y
Brain Tumor Pathol; 2020 Jul; 37(3):100-104. PubMed ID: 32535663
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.
Korshunov A; Okonechnikov K; Schmitt-Hoffner F; Ryzhova M; Sahm F; Stichel D; Schrimpf D; Reuss DE; Sievers P; Suwala AK; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol Commun; 2021 Feb; 9(1):20. PubMed ID: 33536079
[TBL] [Abstract][Full Text] [Related]
4. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging features of FOXR2-activated CNS neuroblastoma: A case series and systematic review.
Shimazaki K; Kurokawa R; Franson A; Kurokawa M; Baba A; Bou-Maroun L; Kim J; Moritani T
J Neuroimaging; 2023; 33(3):359-367. PubMed ID: 36806312
[TBL] [Abstract][Full Text] [Related]
8. Imaging Characteristics of CNS Neuroblastoma-
Tietze A; Mankad K; Lequin MH; Ivarsson L; Mirsky D; Jaju A; Kool M; Hoff KV; Bison B; Löbel U
AJNR Am J Neuroradiol; 2022 Oct; 43(10):1476-1480. PubMed ID: 36137662
[TBL] [Abstract][Full Text] [Related]
9. Pediatric central nervous system (CNS) neuroblastoma: A case report.
Sharkey B; Conner KM; McGarvey CR; Nair A; Dorn A; Reinard K; Gabel B
Surg Neurol Int; 2024; 15():162. PubMed ID: 38840609
[TBL] [Abstract][Full Text] [Related]
10. Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background.
Poh B; Koso H; Momota H; Komori T; Suzuki Y; Yoshida N; Ino Y; Todo T; Watanabe S
Neuro Oncol; 2019 Aug; 21(8):993-1004. PubMed ID: 30976792
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
12.
Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
[TBL] [Abstract][Full Text] [Related]
13. Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified.
Nowak J; Seidel C; Pietsch T; Alkonyi B; Fuss TL; Friedrich C; von Hoff K; Rutkowski S; Warmuth-Metz M
Neuro Oncol; 2015 Aug; 17(8):1157-65. PubMed ID: 25916887
[TBL] [Abstract][Full Text] [Related]
14. [Primitive neuroectodermal tumor of central nervous system with features of ependymoblastoma and neuroblastoma: a clinicopathologic study of 4 cases].
Wang R; Guan W; Wu X; Zhang W; Jiang B; Ma J; Wang L
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):403-7. PubMed ID: 25208992
[TBL] [Abstract][Full Text] [Related]
15. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract][Full Text] [Related]
17. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
Sturm D; Orr BA; Toprak UH; Hovestadt V; Jones DTW; Capper D; Sill M; Buchhalter I; Northcott PA; Leis I; Ryzhova M; Koelsche C; Pfaff E; Allen SJ; Balasubramanian G; Worst BC; Pajtler KW; Brabetz S; Johann PD; Sahm F; Reimand J; Mackay A; Carvalho DM; Remke M; Phillips JJ; Perry A; Cowdrey C; Drissi R; Fouladi M; Giangaspero F; Łastowska M; Grajkowska W; Scheurlen W; Pietsch T; Hagel C; Gojo J; Lötsch D; Berger W; Slavc I; Haberler C; Jouvet A; Holm S; Hofer S; Prinz M; Keohane C; Fried I; Mawrin C; Scheie D; Mobley BC; Schniederjan MJ; Santi M; Buccoliero AM; Dahiya S; Kramm CM; von Bueren AO; von Hoff K; Rutkowski S; Herold-Mende C; Frühwald MC; Milde T; Hasselblatt M; Wesseling P; Rößler J; Schüller U; Ebinger M; Schittenhelm J; Frank S; Grobholz R; Vajtai I; Hans V; Schneppenheim R; Zitterbart K; Collins VP; Aronica E; Varlet P; Puget S; Dufour C; Grill J; Figarella-Branger D; Wolter M; Schuhmann MU; Shalaby T; Grotzer M; van Meter T; Monoranu CM; Felsberg J; Reifenberger G; Snuderl M; Forrester LA; Koster J; Versteeg R; Volckmann R; van Sluis P; Wolf S; Mikkelsen T; Gajjar A; Aldape K; Moore AS; Taylor MD; Jones C; Jabado N; Karajannis MA; Eils R; Schlesner M; Lichter P; von Deimling A; Pfister SM; Ellison DW; Korshunov A; Kool M
Cell; 2016 Feb; 164(5):1060-1072. PubMed ID: 26919435
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous apoptosis and retinoic acid receptor incidence in neuroblastomas and peripheral neuroectodermal tumors.
Farid P; Babosa M; Hauser P; Schuler D; Szende B
Pediatr Hematol Oncol; 2000 Jun; 17(4):315-21. PubMed ID: 10845230
[TBL] [Abstract][Full Text] [Related]
19. MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells.
Modzelewska K; Boer EF; Mosbruger TL; Picard D; Anderson D; Miles RR; Kroll M; Oslund W; Pysher TJ; Schiffman JD; Jensen R; Jette CA; Huang A; Stewart RA
Cell Rep; 2016 Oct; 17(5):1255-1264. PubMed ID: 27783941
[TBL] [Abstract][Full Text] [Related]
20. A rare case of pediatric primary central nervous system differentiating neuroblastoma: an unusual and rare intracranial primitive neuroectodermal tumor (a case report).
Borni M; Znazen M; Mdhaffar N; Boudawara MZ
Pan Afr Med J; 2021; 40():33. PubMed ID: 34795814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
